Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Bone Peptide for Injection
- Development stage
- Unknown
- Lead developer
- Zhitong Biopharma
- Modality
- Peptides
- Administration
- Injection
01
Overview
Compound Bone Peptide for Injection is a marketed injectable peptide preparation developed by ZhiTong for musculoskeletal indications in China. It is a sterile lyophilized compound preparation derived from fresh pig limb bones and whole scorpion, and is described as containing multiple bioactive peptide and growth-factor components including transforming growth factor beta 1 and bone morphogenetic proteins. The product is intended to promote bone metabolism, bone callus formation, and neovascularization to accelerate fracture healing, while peptide components attributed to the scorpion-derived fraction are described as providing anti-inflammatory and analgesic effects through actions on immune cells such as lymphocytes and macrophages. Reported clinical or marketed uses include fracture healing as well as rheumatoid arthritis, osteoporosis, cervical spondylosis, pain relief, and anti-inflammatory treatment.
- Other names
- 复方骨肽注射用compound bone peptide for injectioncompound bone peptide injection
02
Targets
TGFB1 (Transforming growth factor Beta-1 proprotein)BMP (Bone morphogenetic protein family)
Beyond the preview
Go deeper on Compound Bone Peptide for Injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Bone Peptide for Injection.